English

CELTRIX PHARMACEUTICALS INC

EDGAR

Quarterly report amendment (10-Q/A) · filed 2000-04-17

18 filing records in this dataset, filed from 1996-06-27 to 2000-04-17. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

622 thousand USD

1999-12-31 · USD

Exact inputs and evidence

Revenue: 622000 USD Source

Operating margin

-25.24%

1999-12-31 · %

Exact inputs and evidence

Operating Income: -157000 USD Source
Revenue: 622000 USD Source

Operating cash flow

-81 thousand USD

1999-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1514000 USD Source
Operating Cash Flow: -1433000 USD Source

Cash and cash equivalents: 1.24 million USD 1999-12-31 Source
Exact value

1243000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

764 thousand USD

1999-01-01 – 1999-12-31

Exact inputs and evidence

Revenue: 131000 USD · 1998-04-01 – 1999-03-31 Source
Revenue: 79000 USD · 1998-04-01 – 1998-12-31 Source
Revenue: 29000 USD · 1999-04-01 – 1999-06-30 Source
Revenue: 61000 USD · 1999-07-01 – 1999-09-30 Source
Revenue: 622000 USD · 1999-10-01 – 1999-12-31 Source

Net income

-10.5 million USD

1999-01-01 – 1999-12-31

Exact inputs and evidence

Net income: -13399000 USD · 1998-04-01 – 1999-03-31 Source
Net income: -13135000 USD · 1998-04-01 – 1998-12-31 Source
Net income: -8637000 USD · 1999-04-01 – 1999-06-30 Source
Net income: -504000 USD · 1999-07-01 – 1999-09-30 Source
Net income: -1099000 USD · 1999-10-01 – 1999-12-31 Source

Operating cash flow

-2.16 million USD

1999-01-01 – 1999-12-31

Exact inputs and evidence

Operating cash flow: -8930000 USD · 1998-04-01 – 1999-03-31 Source
Operating cash flow: -8281000 USD · 1998-04-01 – 1998-12-31 Source
Operating cash flow: -888000 USD · 1999-04-01 – 1999-06-30 Source
Operating cash flow: -1433000 USD · 1999-04-01 – 1999-09-30 Source
Operating cash flow: -888000 USD · 1999-04-01 – 1999-06-30 Source
Operating cash flow: -1514000 USD · 1999-04-01 – 1999-12-31 Source
Operating cash flow: -1433000 USD · 1999-04-01 – 1999-09-30 Source

Capital expenditure

12 thousand USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Capital expenditure: 77000 USD · 1998-04-01 – 1998-12-31 Source
Capital expenditure: 72000 USD · 1998-04-01 – 1998-09-30 Source
Capital expenditure: 84000 USD · 1998-04-01 – 1999-03-31 Source
Capital expenditure: 77000 USD · 1998-04-01 – 1998-12-31 Source
Capital expenditure: 0 USD · 1999-04-01 – 1999-06-30 Source
Capital expenditure: 0 USD · 1999-04-01 – 1999-09-30 Source
Capital expenditure: 0 USD · 1999-04-01 – 1999-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-04-17.

Financial data available through: 1999-03-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1999-03-31
Operating income: 6 of 11 periods available· newest 1999-03-31
Net income: 6 of 11 periods available· newest 1999-03-31
Operating cash flow: 6 of 11 periods available· newest 1999-03-31
Capital expenditure: 6 of 11 periods available· newest 1999-03-31
Total assets: 6 of 11 periods available· newest 1999-03-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 1999-03-31
Current liabilities: 4 of 11 periods available· newest 1999-03-31
Cash and cash equivalents: 6 of 11 periods available· newest 1999-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-80.2%

Prior period

USD 661,000

1997-04-01 – 1998-03-31
Current period

USD 131,000

1998-04-01 – 1999-03-31

Exact inputs and evidence

131000 − 661000 = -530000 USD

661000 USD · 1997-04-01 – 1998-03-31
Inspect prior input Prior source
131000 USD · 1998-04-01 – 1999-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Year-over-year change in Revenue: -530000 USD Concept: fundies:Revenue Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 131000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3271 Input fundies:Revenue: 661000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3271
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 486,000

Prior period

−USD 12.91 million

1997-04-01 – 1998-03-31
Current period

−USD 13.4 million

1998-04-01 – 1999-03-31

Exact inputs and evidence

-13399000 − -12913000 = -486000 USD

-12913000 USD · 1997-04-01 – 1998-03-31
Inspect prior input Prior source
-13399000 USD · 1998-04-01 – 1999-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Year-over-year change in Net income: -486000 USD Concept: fundies:NetIncome Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13399000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3392 Input fundies:NetIncome: -12913000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3392
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.23 million

Prior period

−USD 11.16 million

1997-04-01 – 1998-03-31
Current period

−USD 8.93 million

1998-04-01 – 1999-03-31

Exact inputs and evidence

-8930000 − -11158000 = 2228000 USD

-11158000 USD · 1997-04-01 – 1998-03-31
Inspect prior input Prior source
-8930000 USD · 1998-04-01 – 1999-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Year-over-year change in Operating cash flow: 2228000 USD Concept: fundies:OperatingCashFlow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -8930000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405 Input fundies:OperatingCashFlow: -11158000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-55.1%

Prior period

USD 187,000

1997-04-01 – 1998-03-31
Current period

USD 84,000

1998-04-01 – 1999-03-31

Exact inputs and evidence

84000 − 187000 = -103000 USD

187000 USD · 1997-04-01 – 1998-03-31
Inspect prior input Prior source
84000 USD · 1998-04-01 – 1999-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Year-over-year change in Capital expenditure: -103000 USD Concept: fundies:CapitalExpenditure Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 84000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413 Input fundies:CapitalExpenditure: 187000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1998-04-01 – 1999-03-31

Revenue USD 131,000 100% of revenue
Operating costs Derived USD 14.26 million 10,887% of revenue
Operating income −USD 14.13 million −10,787% of revenue
Tax, interest and other Derived −USD 732,000 −559% of revenue
Net income −USD 13.4 million −10,228% of revenue

Cash

Operating cash flow −USD 8.93 million −6,817% of revenue
Capital expenditure USD 84,000 64% of revenue
Free cash flow Derived −USD 9.01 million −6,881% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 2,251% of revenue.
1995 Operating loss: operating costs were 1,081% of revenue.
1996 Operating loss: operating costs were 748% of revenue.
1997 Operating loss: operating costs were 2,100% of revenue.
1998 Operating loss: operating costs were 2,268% of revenue.
1999 Operating loss: operating costs were 10,887% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1993-04-01 – 1994-03-31	858000	19315000 Derived	-18457000	-697000 Derived	-17760000	-17007000 Derived	Source 1993-04-01 – 1994-03-31: 858000 USD Inspect Revenue Open source 1993-04-01 – 1994-03-31: -18457000 USD Inspect Operating Income Open source 1993-04-01 – 1994-03-31: -17760000 USD Inspect Net Income Open source 1993-04-01 – 1994-03-31: -16268000 USD Inspect Operating Cash Flow Open source 1993-04-01 – 1994-03-31: 739000 USD Inspect Capital Expenditure Open source
1995 1994-04-01 – 1995-03-31	2200000	23792000 Derived	-21592000	-843000 Derived	-20749000	-19202000 Derived	Source 1994-04-01 – 1995-03-31: 2200000 USD Inspect Revenue Open source 1994-04-01 – 1995-03-31: -21592000 USD Inspect Operating Income Open source 1994-04-01 – 1995-03-31: -20749000 USD Inspect Net Income Open source 1994-04-01 – 1995-03-31: -17018000 USD Inspect Operating Cash Flow Open source 1994-04-01 – 1995-03-31: 2184000 USD Inspect Capital Expenditure Open source
1996 1995-04-01 – 1996-03-31	1750000	13084000 Derived	-11334000	-4088000 Derived	-7246000	-9856000 Derived	Source 1995-04-01 – 1996-03-31: 1750000 USD Inspect Revenue Open source 1995-04-01 – 1996-03-31: -11334000 USD Inspect Operating Income Open source 1995-04-01 – 1996-03-31: -7246000 USD Inspect Net Income Open source 1995-04-01 – 1996-03-31: -9848000 USD Inspect Operating Cash Flow Open source 1995-04-01 – 1996-03-31: 8000 USD Inspect Capital Expenditure Open source
1997 1996-04-01 – 1997-03-31	658000	13818000 Derived	-13160000	-464000 Derived	-12696000	-10977000 Derived	Source 1996-04-01 – 1997-03-31: 658000 USD Inspect Revenue Open source 1996-04-01 – 1997-03-31: -13160000 USD Inspect Operating Income Open source 1996-04-01 – 1997-03-31: -12696000 USD Inspect Net Income Open source 1996-04-01 – 1997-03-31: -10779000 USD Inspect Operating Cash Flow Open source 1996-04-01 – 1997-03-31: 198000 USD Inspect Capital Expenditure Open source
1998 1997-04-01 – 1998-03-31	661000	14992000 Derived	-14331000	-1418000 Derived	-12913000	-11345000 Derived	Source 1997-04-01 – 1998-03-31: 661000 USD Inspect Revenue Open source 1997-04-01 – 1998-03-31: -14331000 USD Inspect Operating Income Open source 1997-04-01 – 1998-03-31: -12913000 USD Inspect Net Income Open source 1997-04-01 – 1998-03-31: -11158000 USD Inspect Operating Cash Flow Open source 1997-04-01 – 1998-03-31: 187000 USD Inspect Capital Expenditure Open source
1999 1998-04-01 – 1999-03-31	131000	14262000 Derived	-14131000	-732000 Derived	-13399000	-9014000 Derived	Source 1998-04-01 – 1999-03-31: 131000 USD Inspect Revenue Open source 1998-04-01 – 1999-03-31: -14131000 USD Inspect Operating Income Open source 1998-04-01 – 1999-03-31: -13399000 USD Inspect Net Income Open source 1998-04-01 – 1999-03-31: -8930000 USD Inspect Operating Cash Flow Open source 1998-04-01 – 1999-03-31: 84000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 131K 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-03-31	Revenue	858000	Revenue: 858000 Open source
19951995-03-31	Revenue	2200000	Revenue: 2200000 Open source
19961996-03-31	Revenue	1750000	Revenue: 1750000 Open source
19971997-03-31	Revenue	658000	Revenue: 658000 Open source
19981998-03-31	Revenue	661000	Revenue: 661000 Open source
19991999-03-31	Revenue	131000	Revenue: 131000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-80.2% 1999

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-03-31	Year over year	No prior comparable period	Revenue: 858000 Open source
19951995-03-31	Year over year	156.4%	Revenue: 2200000 Open source Revenue: 858000 Open source
19961996-03-31	Year over year	-20.5%	Revenue: 1750000 Open source Revenue: 2200000 Open source
19971997-03-31	Year over year	-62.4%	Revenue: 658000 Open source Revenue: 1750000 Open source
19981998-03-31	Year over year	0.5%	Revenue: 661000 Open source Revenue: 658000 Open source
19991999-03-31	Year over year	-80.2%	Revenue: 131000 Open source Revenue: 661000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -10,787% 1999

Net margin -10,228.2% 1999

Free cash flow margin -6,880.9% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-03-31	Operating margin	-2,151.2%	Operating Income: -18457000 Open source Revenue: 858000 Open source
19951995-03-31	Operating margin	-981.5%	Operating Income: -21592000 Open source Revenue: 2200000 Open source
19961996-03-31	Operating margin	-647.7%	Operating Income: -11334000 Open source Revenue: 1750000 Open source
19971997-03-31	Operating margin	-2,000%	Operating Income: -13160000 Open source Revenue: 658000 Open source
19981998-03-31	Operating margin	-2,168.1%	Operating Income: -14331000 Open source Revenue: 661000 Open source
19991999-03-31	Operating margin	-10,787%	Operating Income: -14131000 Open source Revenue: 131000 Open source
19941994-03-31	Net margin	-2,069.9%	Net Income: -17760000 Open source Revenue: 858000 Open source
19951995-03-31	Net margin	-943.1%	Net Income: -20749000 Open source Revenue: 2200000 Open source
19961996-03-31	Net margin	-414.1%	Net Income: -7246000 Open source Revenue: 1750000 Open source
19971997-03-31	Net margin	-1,929.5%	Net Income: -12696000 Open source Revenue: 658000 Open source
19981998-03-31	Net margin	-1,953.6%	Net Income: -12913000 Open source Revenue: 661000 Open source
19991999-03-31	Net margin	-10,228.2%	Net Income: -13399000 Open source Revenue: 131000 Open source
19941994-03-31	Free cash flow margin	-1,982.2%	Revenue: 858000 Open source Operating Cash Flow: -16268000 Open source Capital Expenditure: 739000 Open source
19951995-03-31	Free cash flow margin	-872.8%	Revenue: 2200000 Open source Operating Cash Flow: -17018000 Open source Capital Expenditure: 2184000 Open source
19961996-03-31	Free cash flow margin	-563.2%	Revenue: 1750000 Open source Operating Cash Flow: -9848000 Open source Capital Expenditure: 8000 Open source
19971997-03-31	Free cash flow margin	-1,668.2%	Revenue: 658000 Open source Operating Cash Flow: -10779000 Open source Capital Expenditure: 198000 Open source
19981998-03-31	Free cash flow margin	-1,716.3%	Revenue: 661000 Open source Operating Cash Flow: -11158000 Open source Capital Expenditure: 187000 Open source
19991999-03-31	Free cash flow margin	-6,880.9%	Revenue: 131000 Open source Operating Cash Flow: -8930000 Open source Capital Expenditure: 84000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -8.9M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-03-31	Operating cash flow	-16268000	Operating Cash Flow: -16268000 Open source
19951995-03-31	Operating cash flow	-17018000	Operating Cash Flow: -17018000 Open source
19961996-03-31	Operating cash flow	-9848000	Operating Cash Flow: -9848000 Open source
19971997-03-31	Operating cash flow	-10779000	Operating Cash Flow: -10779000 Open source
19981998-03-31	Operating cash flow	-11158000	Operating Cash Flow: -11158000 Open source
19991999-03-31	Operating cash flow	-8930000	Operating Cash Flow: -8930000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -9M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-03-31	Free cash flow	-17007000	Operating Cash Flow: -16268000 Open source Capital Expenditure: 739000 Open source
19951995-03-31	Free cash flow	-19202000	Operating Cash Flow: -17018000 Open source Capital Expenditure: 2184000 Open source
19961996-03-31	Free cash flow	-9856000	Operating Cash Flow: -9848000 Open source Capital Expenditure: 8000 Open source
19971997-03-31	Free cash flow	-10977000	Operating Cash Flow: -10779000 Open source Capital Expenditure: 198000 Open source
19981998-03-31	Free cash flow	-11345000	Operating Cash Flow: -11158000 Open source Capital Expenditure: 187000 Open source
19991999-03-31	Free cash flow	-9014000	Operating Cash Flow: -8930000 Open source Capital Expenditure: 84000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-03-31	Liabilities / assets	Not reported	Total Assets: 44089000 Open source
1995-03-31	Liabilities / assets	Not reported	Total Assets: 35024000 Open source
1996-03-31	Liabilities / assets	Not reported	Total Assets: 30145000 Open source
1997-03-31	Liabilities / assets	Not reported	Total Assets: 16956000 Open source
1998-03-31	Liabilities / assets	Not reported	Total Assets: 17876000 Open source
1999-03-31	Liabilities / assets	Not reported	Total Assets: 4501000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.17× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-03-31	Current assets / current liabilities	Not reported	No source recorded
1995-03-31	Current assets / current liabilities	Not reported	No source recorded
19961996-03-31	Current assets / current liabilities	9.22×	Current Assets: 17838000 Open source Current Liabilities: 1934000 Open source
19971997-03-31	Current assets / current liabilities	3.5×	Current Assets: 5985000 Open source Current Liabilities: 1708000 Open source
19981998-03-31	Current assets / current liabilities	3.63×	Current Assets: 8132000 Open source Current Liabilities: 2242000 Open source
19991999-03-31	Current assets / current liabilities	1.17×	Current Assets: 1430000 Open source Current Liabilities: 1221000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1993-04-01 – 1994-03-31	−USD 17.76 million Exact value Exact value: -17760000 USD 1993-04-01 – 1994-03-31: -17760000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELTRIX PHARMACEUTICALS INC · 1994-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Net Income: -17760000 USD Concept: fundies:NetIncome Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ANetIncome&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:NetIncome: -17760000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-96-001052.txt#1853 The citation records this snapshot. The page link may show a newer release later.	−USD 16.27 million Exact value Exact value: -16268000 USD 1993-04-01 – 1994-03-31: -16268000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELTRIX PHARMACEUTICALS INC · 1994-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Operating Cash Flow: -16268000 USD Concept: fundies:OperatingCashFlow Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3AOperatingCashFlow&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16268000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-96-001052.txt#1863 The citation records this snapshot. The page link may show a newer release later.	USD 739,000 Exact value Exact value: 739000 USD 1993-04-01 – 1994-03-31: 739000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELTRIX PHARMACEUTICALS INC · 1994-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Capital Expenditure: 739000 USD Concept: fundies:CapitalExpenditure Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ACapitalExpenditure&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 739000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-96-001052.txt#1869 The citation records this snapshot. The page link may show a newer release later.	−USD 17.01 million Calculation and evidence -16268000 − 739000 USD Exact free cash flow: -17007000 USD 1993-04-01 – 1994-03-31: -16268000 USD · Inspect Operating Cash Flow · Source 1993-04-01 – 1994-03-31: 739000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELTRIX PHARMACEUTICALS INC · 1994-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Free cash flow: -17007000 USD Concept: free-cash-flow Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16268000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-96-001052.txt#1863 Input fundies:CapitalExpenditure: 739000 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-96-001052.txt#1869 The citation records this snapshot. The page link may show a newer release later.
1995 1994-04-01 – 1995-03-31	−USD 20.75 million Exact value Exact value: -20749000 USD 1994-04-01 – 1995-03-31: -20749000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELTRIX PHARMACEUTICALS INC · 1995-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Net Income: -20749000 USD Concept: fundies:NetIncome Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ANetIncome&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:NetIncome: -20749000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-97-002698.txt#2343 The citation records this snapshot. The page link may show a newer release later.	−USD 17.02 million Exact value Exact value: -17018000 USD 1994-04-01 – 1995-03-31: -17018000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELTRIX PHARMACEUTICALS INC · 1995-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Operating Cash Flow: -17018000 USD Concept: fundies:OperatingCashFlow Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3AOperatingCashFlow&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17018000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-97-002698.txt#2354 The citation records this snapshot. The page link may show a newer release later.	USD 2.18 million Exact value Exact value: 2184000 USD 1994-04-01 – 1995-03-31: 2184000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELTRIX PHARMACEUTICALS INC · 1995-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Capital Expenditure: 2184000 USD Concept: fundies:CapitalExpenditure Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ACapitalExpenditure&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2184000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-97-002698.txt#2361 The citation records this snapshot. The page link may show a newer release later.	−USD 19.2 million Calculation and evidence -17018000 − 2184000 USD Exact free cash flow: -19202000 USD 1994-04-01 – 1995-03-31: -17018000 USD · Inspect Operating Cash Flow · Source 1994-04-01 – 1995-03-31: 2184000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELTRIX PHARMACEUTICALS INC · 1995-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Free cash flow: -19202000 USD Concept: free-cash-flow Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17018000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-97-002698.txt#2354 Input fundies:CapitalExpenditure: 2184000 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-97-002698.txt#2361 The citation records this snapshot. The page link may show a newer release later.
1996 1995-04-01 – 1996-03-31	−USD 7.25 million Exact value Exact value: -7246000 USD 1995-04-01 – 1996-03-31: -7246000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELTRIX PHARMACEUTICALS INC · 1996-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Net Income: -7246000 USD Concept: fundies:NetIncome Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ANetIncome&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:NetIncome: -7246000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-98-003301.txt#2698 The citation records this snapshot. The page link may show a newer release later.	−USD 9.85 million Exact value Exact value: -9848000 USD 1995-04-01 – 1996-03-31: -9848000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELTRIX PHARMACEUTICALS INC · 1996-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Operating Cash Flow: -9848000 USD Concept: fundies:OperatingCashFlow Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3AOperatingCashFlow&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9848000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-98-003301.txt#2709 The citation records this snapshot. The page link may show a newer release later.	USD 8,000 Exact value Exact value: 8000 USD 1995-04-01 – 1996-03-31: 8000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELTRIX PHARMACEUTICALS INC · 1996-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Capital Expenditure: 8000 USD Concept: fundies:CapitalExpenditure Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ACapitalExpenditure&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-98-003301.txt#2716 The citation records this snapshot. The page link may show a newer release later.	−USD 9.86 million Calculation and evidence -9848000 − 8000 USD Exact free cash flow: -9856000 USD 1995-04-01 – 1996-03-31: -9848000 USD · Inspect Operating Cash Flow · Source 1995-04-01 – 1996-03-31: 8000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELTRIX PHARMACEUTICALS INC · 1996-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Free cash flow: -9856000 USD Concept: free-cash-flow Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9848000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-98-003301.txt#2709 Input fundies:CapitalExpenditure: 8000 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-98-003301.txt#2716 The citation records this snapshot. The page link may show a newer release later.
1997 1996-04-01 – 1997-03-31	−USD 12.7 million Exact value Exact value: -12696000 USD 1996-04-01 – 1997-03-31: -12696000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELTRIX PHARMACEUTICALS INC · 1997-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Net Income: -12696000 USD Concept: fundies:NetIncome Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ANetIncome&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:NetIncome: -12696000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3392 The citation records this snapshot. The page link may show a newer release later.	−USD 10.78 million Exact value Exact value: -10779000 USD 1996-04-01 – 1997-03-31: -10779000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELTRIX PHARMACEUTICALS INC · 1997-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Operating Cash Flow: -10779000 USD Concept: fundies:OperatingCashFlow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3AOperatingCashFlow&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10779000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405 The citation records this snapshot. The page link may show a newer release later.	USD 198,000 Exact value Exact value: 198000 USD 1996-04-01 – 1997-03-31: 198000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELTRIX PHARMACEUTICALS INC · 1997-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Capital Expenditure: 198000 USD Concept: fundies:CapitalExpenditure Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ACapitalExpenditure&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 198000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413 The citation records this snapshot. The page link may show a newer release later.	−USD 10.98 million Calculation and evidence -10779000 − 198000 USD Exact free cash flow: -10977000 USD 1996-04-01 – 1997-03-31: -10779000 USD · Inspect Operating Cash Flow · Source 1996-04-01 – 1997-03-31: 198000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELTRIX PHARMACEUTICALS INC · 1997-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Free cash flow: -10977000 USD Concept: free-cash-flow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10779000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405 Input fundies:CapitalExpenditure: 198000 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413 The citation records this snapshot. The page link may show a newer release later.
1998 1997-04-01 – 1998-03-31	−USD 12.91 million Exact value Exact value: -12913000 USD 1997-04-01 – 1998-03-31: -12913000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELTRIX PHARMACEUTICALS INC · 1998-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Net Income: -12913000 USD Concept: fundies:NetIncome Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ANetIncome&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:NetIncome: -12913000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3392 The citation records this snapshot. The page link may show a newer release later.	−USD 11.16 million Exact value Exact value: -11158000 USD 1997-04-01 – 1998-03-31: -11158000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELTRIX PHARMACEUTICALS INC · 1998-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Operating Cash Flow: -11158000 USD Concept: fundies:OperatingCashFlow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3AOperatingCashFlow&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11158000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405 The citation records this snapshot. The page link may show a newer release later.	USD 187,000 Exact value Exact value: 187000 USD 1997-04-01 – 1998-03-31: 187000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELTRIX PHARMACEUTICALS INC · 1998-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Capital Expenditure: 187000 USD Concept: fundies:CapitalExpenditure Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ACapitalExpenditure&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 187000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413 The citation records this snapshot. The page link may show a newer release later.	−USD 11.35 million Calculation and evidence -11158000 − 187000 USD Exact free cash flow: -11345000 USD 1997-04-01 – 1998-03-31: -11158000 USD · Inspect Operating Cash Flow · Source 1997-04-01 – 1998-03-31: 187000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELTRIX PHARMACEUTICALS INC · 1998-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Free cash flow: -11345000 USD Concept: free-cash-flow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11158000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405 Input fundies:CapitalExpenditure: 187000 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413 The citation records this snapshot. The page link may show a newer release later.
1999 1998-04-01 – 1999-03-31	−USD 13.4 million Exact value Exact value: -13399000 USD 1998-04-01 – 1999-03-31: -13399000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Net Income: -13399000 USD Concept: fundies:NetIncome Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ANetIncome&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:NetIncome: -13399000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3392 The citation records this snapshot. The page link may show a newer release later.	−USD 8.93 million Exact value Exact value: -8930000 USD 1998-04-01 – 1999-03-31: -8930000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Operating Cash Flow: -8930000 USD Concept: fundies:OperatingCashFlow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3AOperatingCashFlow&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8930000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405 The citation records this snapshot. The page link may show a newer release later.	USD 84,000 Exact value Exact value: 84000 USD 1998-04-01 – 1999-03-31: 84000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Capital Expenditure: 84000 USD Concept: fundies:CapitalExpenditure Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395/explain?concept=fundies%3ACapitalExpenditure&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413 The citation records this snapshot. The page link may show a newer release later.	−USD 9.01 million Calculation and evidence -8930000 − 84000 USD Exact free cash flow: -9014000 USD 1998-04-01 – 1999-03-31: -8930000 USD · Inspect Operating Cash Flow · Source 1998-04-01 – 1999-03-31: 84000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELTRIX PHARMACEUTICALS INC · 1999-03-31 CELTRIX PHARMACEUTICALS INC (edgar:871395) Free cash flow: -9014000 USD Concept: free-cash-flow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/871395?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8930000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3405 Input fundies:CapitalExpenditure: 84000 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/871395/0000891618-99-002974.txt#3413 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

18 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 0000871395, 871395, edgar:871395

CELTRIX PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1998-04-01 – 1999-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation